1. Home
  2. HAE vs ACT Comparison

HAE vs ACT Comparison

Compare HAE & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • ACT
  • Stock Information
  • Founded
  • HAE 1971
  • ACT 1981
  • Country
  • HAE United States
  • ACT United States
  • Employees
  • HAE N/A
  • ACT N/A
  • Industry
  • HAE Medical/Dental Instruments
  • ACT Specialty Insurers
  • Sector
  • HAE Health Care
  • ACT Finance
  • Exchange
  • HAE Nasdaq
  • ACT Nasdaq
  • Market Cap
  • HAE 4.4B
  • ACT 5.3B
  • IPO Year
  • HAE 1991
  • ACT 2021
  • Fundamental
  • Price
  • HAE $81.56
  • ACT $33.83
  • Analyst Decision
  • HAE Strong Buy
  • ACT Buy
  • Analyst Count
  • HAE 9
  • ACT 4
  • Target Price
  • HAE $108.78
  • ACT $37.25
  • AVG Volume (30 Days)
  • HAE 494.4K
  • ACT 253.3K
  • Earning Date
  • HAE 02-06-2025
  • ACT 02-04-2025
  • Dividend Yield
  • HAE N/A
  • ACT 2.11%
  • EPS Growth
  • HAE N/A
  • ACT 6.96
  • EPS
  • HAE 2.41
  • ACT 4.29
  • Revenue
  • HAE $1,361,223,000.00
  • ACT $1,196,188,000.00
  • Revenue This Year
  • HAE $7.63
  • ACT N/A
  • Revenue Next Year
  • HAE $4.40
  • ACT $4.81
  • P/E Ratio
  • HAE $33.82
  • ACT $7.89
  • Revenue Growth
  • HAE 9.84
  • ACT 5.45
  • 52 Week Low
  • HAE $70.25
  • ACT $26.13
  • 52 Week High
  • HAE $97.97
  • ACT $37.42
  • Technical
  • Relative Strength Index (RSI)
  • HAE 44.19
  • ACT 41.45
  • Support Level
  • HAE $80.65
  • ACT $33.77
  • Resistance Level
  • HAE $83.32
  • ACT $34.95
  • Average True Range (ATR)
  • HAE 2.13
  • ACT 0.59
  • MACD
  • HAE -0.63
  • ACT -0.10
  • Stochastic Oscillator
  • HAE 11.31
  • ACT 25.12

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About ACT Enact Holdings Inc.

Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers they will use for the placement of mortgage insurance written on loans they originate. The company is engaged in the business of writing and assuming residential mortgage guaranty insurance.

Share on Social Networks: